Breadcrumb AMCP.org Policy & Advocacy Letters, Statements & Analysis AMCP Submits Comments to the FDA on Potential Areas of Focus for the Opioid Policy Steering Committee AMCP Submits Comments to the FDA on Potential Areas of Focus for the Opioid Policy Steering Committee 12/28/17 Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page AMCP Submits Comments to the FDA on Potential Areas of Focus for the Opioid Policy Steering Committee.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page